Literature DB >> 2894347

A PvuII polymorphism in the 5' flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration.

A M Kessling1, R Taylor, A Temple, J Hutson, A Hidalgo, S E Humphries.   

Abstract

We have used a 1.05-kb unique genomic fragment from the 5' end of the apolipoprotein (apo) CIII gene to identify a restriction fragment length polymorphism (RFLP) detected with the restriction enzyme PvuII, in the apoCIII-apoAIV intergenic region. In a sample of 220 normolipidaemic individuals from the UK population, the frequency of the rare allele, VB2 is 0.054. The PvuII polymorphism is in apparent linkage equilibrium with three other RFLPs of this gene cluster, detected with the restriction enzymes XmnI, PstI and SstI, but in linkage disequilibrium with an RFLP in the apo-CIII gene also detected with PvuII. Taken together, these five RFLPs have a PIC (polymorphism information content) value of 0.8, and therefore are informative for genetic studies. Individuals with the genotype VB1VB2 had lower mean concentrations of apoAI, and HDL-cholesterol than individuals with the genotype VB1VB1. However these differences were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894347     DOI: 10.1007/bf00291668

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  Pvu II RFLP in the 5' of the human apolipoprotein B gene.

Authors:  P M Frossard; P A Gonzalez; A A Protter; R T Coleman; H Funke; G Assmann
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

2.  Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population.

Authors:  A Rees; J Stocks; H Paul; Y Ohuchi; D Galton
Journal:  Hum Genet       Date:  1986-02       Impact factor: 4.132

3.  RFLPs for the human apolipoprotein B gene: HincII and PvuII.

Authors:  C Darnfors; J Nilsson; A A Protter; P Carlsson; P J Talmud; S E Humphries; J Whalström; O Wiklund; G Bjursell
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

4.  Nonuniform recombination within the human beta-globin gene cluster.

Authors:  A Chakravarti; K H Buetow; S E Antonarakis; P G Waber; C D Boehm; H H Kazazian
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

5.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1984-09       Impact factor: 3.710

Review 6.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

8.  A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis.

Authors:  S E Humphries; A M Kessling; B Horsthemke; J A Donald; M Seed; N Jowett; M Holm; D J Galton; V Wynn; R Williamson
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

9.  A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals.

Authors:  A M Kessling; B Horsthemke; S E Humphries
Journal:  Clin Genet       Date:  1985-10       Impact factor: 4.438

10.  Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI--discovery of a new genetic polymorphism in the apo AI gene.

Authors:  J J Seilhamer; A A Protter; P Frossard; B Levy-Wilson
Journal:  DNA       Date:  1984-08
View more
  6 in total

1.  Extended haplotypes and linkage disequilibrium between 11 markers at the APOA1-C3-A4 gene cluster on chromosome 11.

Authors:  P Benlian; C Boileau; N Loux; D Pastier; J Masliah; M Coulon; M Nigou; A Ragab; J Guimard; J B Ruidavets
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

2.  Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster.

Authors:  M B Haviland; A M Kessling; J Davignon; C F Sing
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

3.  Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones.

Authors:  A Kessling; S Ouellette; O Bouffard; A Chamberland; C Bétard; E Selinger; M Xhignesse; S Lussier-Cacan; J Davignon
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

4.  Gene and gene-product variation in the apolipoprotein A-I/C-III/A-IV cluster in the Dogrib Indians of the Northwest Territories.

Authors:  S A Cole; E J Szathmary; R E Ferrell
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

5.  Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.

Authors:  C F Xu; M N Nanjee; J Savill; P J Talmud; F Angelico; M Del Ben; R Antonini; B Mazzarella; N Miller; S E Humphries
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.